DOP007 Efficacy of vedolizumab induction therapy on clinical and endoscopic activity in patients with anti-tumour necrosis factor alpha-resistant inflammatory bowel disease
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.